Harold Pollack to Narcotic Antagonists
This is a "connection" page, showing publications Harold Pollack has written about Narcotic Antagonists.
Connection Strength
0.652
-
State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder. Psychiatr Serv. 2018 04 01; 69(4):448-455.
Score: 0.139
-
Non-buprenorphine opioid utilization among patients using buprenorphine. Addiction. 2017 Jun; 112(6):1045-1053.
Score: 0.132
-
Addressing the Fentanyl Threat to Public Health. N Engl J Med. 2017 Feb 16; 376(7):605-607.
Score: 0.132
-
Adoption of evidence-based clinical innovations: the case of buprenorphine use by opioid treatment programs. Med Care Res Rev. 2014 Feb; 71(1):43-60.
Score: 0.104
-
HIV testing in the nation's opioid treatment programs, 2005-2011: the role of state regulations. Health Serv Res. 2014 Feb; 49(1):230-48.
Score: 0.103
-
Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US. JAMA Netw Open. 2020 11 02; 3(11):e2023677.
Score: 0.043